Turn $800 into $50,000 Trading Penny Stocks

Welcome to the #1 Rated Penny Stock Newsletter 2 Years Running In

 4 days my pricing goes up nearly $150 per quarter – Act now and SAVE! Earlier today I showed you how one trader specifically turned $4k into $25k following my advice.

 I understand not all traders have $4k to start, but what about $800? I just wanted to say thanks for what you’ve done with the chat room the past week in regards to cleaning it up. It’s much more focused and is just a great place to be! Also, I saw on the front page the story about royal and his success and I too wanted to say thank you for helping me grow my account.

At the middle of last summer I had hit rock bottom in both my trading confidence and my account. I had a total of $800. So, I took you advice and watched all of your videos and made sure to watch how you and other good traders traded in the chat room. Needless to say, that $800 is now over $50,000 and growing. That’s including taking out money for college (Which we all know ain’t cheap), paying for an engagement ring, and other expenses.
So, again, thank you so much for all you do! This service is the best and I am not going anywhere! Keep up the incredible work! – Tanner Metrics and results don’t lie, nor does my service! Come September my SuperNova Elite price will be rising nearly $150 per quarter and my SuperNova Combo will be rising nearly $200 per quarter.

View to Original post :- Click Here

Turn $4,000 into $25,000, Let Me Show You How

Hello Penny Stock Traders, The question I get from most people who inquire about my SuperNova Elite service is “Can I take $5,000 and turn it into $25,000 or more trading penny stocks?” The answer simply is YES. Why do I say that you ask? Well, I have members who do it all the time. As a matter of fact,

I have had several members accomplish this $25,000 goal just by using my Premium services they get with the SuperNova Elite newsletter. Just take a look at what Royal told me yesterday….. “Jeff, in just over 8 months I took a $4,200 account and turned it over $25,000 following your trade alerts and also making my own trades which I learned how to do from your educational videos.

I couldn’t have done this without your service. – Royal 8/26″ Listen, my service is second to none when it comes to educational learning material, volatile and profitable alerts and spoon feeding you buy and sell email and text messages. As a matter of fact, our Premium Chat Room is the largest for penny stocks on the Net today. SuperNova Elite Gives You Buy and sell emails Buy and sell text message alerts Price of alerts $.001 to $5.00 Scalp Trades Swing Trades Short Term Trades 105 Educational Video Lessons – More learning material than any other service Live Stock Chat Room 6 Moderators that specialize in a variety of areas Nightly Stock Scans Portfolio Analysis of our trades Weekly Seminars 24/7 Email Support

View to Original post :- Click Here

Big Mover on the Nasdaq; Genetic Technologies Limited (GENE)

U.S. equity market has rebounded sharply in trading today as market sentiment has been lifted by some positive economic data from Europe and China. All three major indexes have risen sharply. Among the biggest gainers on the Nasdaq today is Genetic Technologies Limited (ADR) (NASDAQ: GENE), an Australia-based company providing genetic testing services.

GENE shares are surging after the company today said that its wholly-owned subsidiary Phenogen Sciences Inc. executed an agreement with InterWest Health of Missoula, Montana, U.S. to use the InterWest provider network. A regional provider, InterWest Health services seven states in north-west U.S. The states include Montana, Idaho and Washington.

 This is the eighth such agreement executed between GENE and similar U.S. Preferred Provider Organizations (PPOs). Apart from InterWest Health, the company has executed agreements with FedMed Inc., MultiPlan Network, Three Rivers Provider Network, Prime Health Services, National Preferred Provider Network/PlanCare America/Ohio Preferred Network LLC, Galaxy Health Network and Fortified Provider Network. These agreements are certainly benefiting GENE as evidenced by the company’s performance during the quarter ended June 30, 2013. During the quarter, the company received a record number of BREVAGen™ test samples. Total patient samples received during the quarter stood at 599, which represents growth of over 48% on a quarter-over-quarter basis.

 For the first six months of 2013, total BREVAGen™ test samples received stood at 1,547, which represents a growth of over 272% on a year-over-year basis.

 GENE, recently, also executed a merger agreement with Sydney-based Simavita Holdings Limited. The agreement was executed by the company’s Canadian-listed subsidiary, Gtech International Resources Limited. Gene Technologies CEO Alison Mew said that the company is extremely pleased that Gtech entered into a transaction that will see all of its shareholders, including GENE, benefit from the planned expansion of the exciting Simavita business into the huge North American market and beyond. Mew also said that the transition of management to the incoming Simavita team will allow Genetic Technologies to maintain focus on the expansion of its U.S. business through the growth of its flagship BREVAGen™ test.

Apart from these positive developments, GENE is also expected to benefit from an increase in demand for genetic testing. According to a study conducted by the research arm of UnitedHealth Group, spending on genetic testing in the U.S. alone is expected to be between $15 billion and $25 billion by 2021. UnitedHealth expects double digit growth over the next few years. GENE, with its recent developments, is certainly well-positioned to capitalize on this growth. Not surprisingly, the company’s shares have been seeing increasing interest from investors.

 GENE shares have surged in trading today, striking an intra-day high of $2.81. At last check, the stock was trading 24.09% higher at $2.73. The rally today has pushed GENE shares above their 50-and 200-day moving averages, which is a strong bullish signal. The bullish trend is further confirmed by the MACD chart. The MACD has crossed over the signal line. GENE shares are expected to face resistance at around $2.80. If the stock breaks through this level then the next resistance level will be at around $3.
View to Original post :- Click Here

Big Mover on the Nasdaq; NF Energy Saving Corp. (NFEC)

China-based NF Energy Saving Corp. (NASDAQ: NFEC) today announced the signing of an energy service contract in Dongguan, China. The announcement sent NFEC shares sharply higher.

NF Energy Saving, which manufactures large diameter energy efficient flow control systems for a range of industries in China, signed an energy efficiency service contract with Dongguan Xianjia Plastic Products Company. The contract was signed through Liaoning NF Energy, which is NFEC’s wholly-owned subsidiary.

Under the terms of the contract, NFEC will retrofit 58 units of Dongguan Xianjia’s injection molding machines, which will result in energy saving of up to 40%. The contract certainly highlights the increasing demand for energy efficient products and services in China. In the last few years, the Chinese government has also pushed for energy saving products and services. This certainly augurs well for NFEC.
Last week, NF Energy Saving had reported its financial results for the second quarter ended June 30, 2013. For the quarter, the company’s total revenue stood at $1.47 million. For the first six months of 2013, the company’s revenue stood at $2.77 million.

NFEC’s gross profit for the second quarter stood at $0.43 million. For the six-month period ended June 30, 2013, NFEC reported a gross profit of $0.84 million. Net income for the second quarter was $52,017, while for the first half of 2013 it was $61,782.

Earlier this month, NF Energy Saving also announced the establishment of a new subsidiary, NF Energy Corporation Guangdong Subsidiary. The subsidiary has been established in Guangzhou, China. Through the subsidiary, the company is looking to improve the development of its energy saving products and enable it to take advantage of the expanding energy saving industry in China.

Given all these positive developments, it is not surprising that NFEC shares have been significant interests from investors recently. The stock surged 22.63% to finish at $2.33 in trading today after striking a 52-week high of $2.88. NFEC shares have now gained more than 86% in just the last three trading sessions. The stock is nearly 250% in the last one month. Year-to-date, the stock has gained more than 129%.
The gains in the last one month have pushed NFEC shares above their 50-day and 200-day moving averages. This is a strong bullish signal. The stock’s MACD chart further confirms the bullish trend. The MACD is currently trading above the signal line as well as the zero-line. Also, the MACD histogram is indicating increasing upward momentum. Certainly, technical indicators suggest that market sentiment is bullish on the stock at the moment.

While technical indicators point to further gains in NFEC shares in the near-term, the increasing demand for energy saving products and services in China makes NFEC an excellent long-term bet as well. Also, the recent developments at NFEC suggest that the company is well-positioned to capitalize on the increasing demand for energy products and services in China. All these make NFEC a stock to watch in the long-term as well.
View to Original post:Click Here

Will the Pullback in Equities Continue?

On Friday, U.S. equity market slipped, with all three benchmark index ending the day in red. Stocks also fell for the week. The pullback last week has prompted investors to ask the question whether the rally in U.S. 
equity market is coming to an end. In an interview with CNBC last week, Marc Faber said that he expects a 1987 like crash in equities in the second half of the year.

Faber is not the only one expecting a pullback right now. Speaking to CNBC, John Stoltzfus, Chief Investment Strategist at Oppenheimer, said that there is a considerable opportunity for profit taking given that the market is still not certain about the timing of the Federal Reserve’s plans to scale back its bond purchase program.

 While the broader market struggled last week, basic materials sector enjoyed an excellent run as some robust economic data from China lifted investors’ sentiment on commodities. Copper prices rose sharply last week. Shares of mining giants such as BHP Billiton (ADR) (NYSE: BHP), and Rio Tinto Plc (ADR) (NYSE: RIO). It will be interesting to see if the sector can continue its excellent run amid signs of improvement in the Chinese economy.
 Original Post :- View to Original post Click here

Apple to Launch Next Generation of iPhone Next Month

According to a report from All Things D, technology giant Apple Inc. (NASDAQ: AAPL) is expected to launch its next-generation iPhone on September 10. The report was also confirmed by USA Today. However, a spokeswoman for Apple denied the report, saying the company does not comment on rumors. The next generation iPhone from Apple will be keenly watched as the Cupertino, California-based company has been facing increasing competition from Samsung lately.

 Apple shares, which struck an all-time high of $705.07 in September last year, have struggled since last October. It will be interesting to see if the next generation iPhone can give the company’s shares a boost. Apple is not the only smartphone maker in news today.

BlackBerry Ltd. (NASDAQ: BBRY) is also expected to remain in focus today after the struggling company said that it has set up committee to look at its strategic options, which include a possible sale. BBRY once dominated the smartphone market; however, in the last three years the company has struggled to compete against the likes of iPhone and Android-operated phones. Reports of BBRY considering a possible sale first appeared on Friday, following which the stock surged more than 9%.

Original Post :- View to Original post Click here

Automakers Near 52-Week High

U.S. automakers Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) are hovering around their 52-week high as improving U.S. auto sales are continuing to benefit the two companies. Last week, a report showed that auto sales rose to pre-crisis level in the month of July. Both Ford and GM registered a sharp rise in July U.S. auto sales

While Ford registered an 11% increase in U.S. auto sales, GM posted a 16% increase in sales. More importantly, the outlook for U.S. auto sales remains robust.One of the major factors behind improving auto sales has been increasing demand for pickup trucks, which is being driven by an ongoing improvement in the economy.

Last week, a data from the Commerce Department showed that the U.S. economy grew more than forecast in the second quarter of 2013, while manufacturing activity accelerated in the month of July.
 The big question is whether you should buy automakers at current levels. The answer is probably yes as the recovery in the auto market is expected to continue, benefiting both Ford and GM. In terms of valuation, both Ford and GM are looking attractive right. Ford is trading on a P/E ratio of just 11.52, while GM is currently trading on a P/E ratio of 13.25. Given these factors, there is certainly further upside potential in automaker
 Original post :- Click here

Oil Majors Disappoint

Exxon Mobil Corporation (NYSE: XOM) and Chevron Corporation (NYSE: CVX) came out with their quarterly results late last week. Both companies posted a sharp decline in their second-quarter earnings as weaker refining results had a significant impact on the bottom-line. Major integrated oil companies had seen a revival of their refinery businesses in the last few quarters as lower U.S. crude oil prices,

 thanks to the shale revolution, boosted margins. However, with the spread between U.S. crude and Brent crude in London narrowing in the second quarter, margins at U.S. refiners have come under pressure. At Chevron, refining and marketing earnings fell 83%. Apart from higher U.S. crude oil prices, Chevron’s refinery and marketing earnings were negatively impacted by a sharp drop in refinery crude input due to the fire at the company’s Richmond, California plant in August last year.

The plant started in April this year. Meanwhile, Exxon also reported a drop in its refinery margins. The company’s output also dropped as refineries were undergoing maintenance. The narrowing of the spread between U.S. crude and Brent is expected to continue to hurt major integrated oil companies’ refining businesses. Therefore, one can expect the next few quarters to be challenging for Exxon and Chevron.

Original  Post :- View to Original Post Click here